64 related articles for article (PubMed ID: 25264963)
21. Long-term fluoxetine treatment of a large number of obsessive-compulsive patients.
Levine R; Hoffman JS; Knepple ED; Kenin M
J Clin Psychopharmacol; 1989 Aug; 9(4):281-3. PubMed ID: 2504781
[TBL] [Abstract][Full Text] [Related]
22. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients.
Zohar J; Kaplan Z; Benjamin J
J Clin Psychiatry; 1993 Oct; 54(10):385-8. PubMed ID: 7903293
[TBL] [Abstract][Full Text] [Related]
23. Comparison of obsessions and compulsions in patients with anorexia nervosa and obsessive compulsive disorder.
Bastiani AM; Altemus M; Pigott TA; Rubenstein C; Weltzin TE; Kaye WH
Biol Psychiatry; 1996 Jun; 39(11):966-9. PubMed ID: 9162209
[TBL] [Abstract][Full Text] [Related]
24. Low MMPI diagnostic performance for the DSM-III--R obsessive-compulsive personality disorder.
Schotte C; De Doncker D; Maes M; Cluydts R; Cosyns P
Psychol Rep; 1991 Dec; 69(3 Pt 1):795-800. PubMed ID: 1784669
[TBL] [Abstract][Full Text] [Related]
25. Obsessive-compulsive disorder and trazodone.
Prasad AJ
Am J Psychiatry; 1984 Apr; 141(4):612-3. PubMed ID: 6703152
[No Abstract] [Full Text] [Related]
26. Neuropsychological performance in children and adolescents with obsessive-compulsive disorder and influence of clinical variables.
Andrés S; Boget T; Lázaro L; Penadés R; Morer A; Salamero M; Castro-Fornieles J
Biol Psychiatry; 2007 Apr; 61(8):946-51. PubMed ID: 17157271
[TBL] [Abstract][Full Text] [Related]
27. Fluoxetine treatment of obsessive-compulsive disorder: an open clinical trial.
Liebowitz MR; Hollander E; Schneier F; Campeas R; Hatterer J; Papp L; Fairbanks J; Sandberg D; Davies S; Stein M
J Clin Psychopharmacol; 1989 Dec; 9(6):423-7. PubMed ID: 2687337
[TBL] [Abstract][Full Text] [Related]
28. Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.
Greist JH; Jefferson JW; Rosenfeld R; Gutzmann LD; March JS; Barklage NE
J Clin Psychiatry; 1990 Jul; 51(7):292-7. PubMed ID: 2195006
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of comorbid obsessive-compulsive disorder with aripiprazole in three patients with bipolar disorder.
Uguz F
Gen Hosp Psychiatry; 2010; 32(5):556-8. PubMed ID: 20851277
[TBL] [Abstract][Full Text] [Related]
30. Sarcosine therapy for obsessive compulsive disorder: a prospective, open-label study.
Wu PL; Tang HS; Lane HY; Tsai CA; Tsai GE
J Clin Psychopharmacol; 2011 Jun; 31(3):369-74. PubMed ID: 21508860
[TBL] [Abstract][Full Text] [Related]
31. Nicotine treatment of obsessive-compulsive disorder.
Lundberg S; Carlsson A; Norfeldt P; Carlsson ML
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1195-9. PubMed ID: 15610934
[TBL] [Abstract][Full Text] [Related]
32. Adderall for obsessive-compulsive disorder.
Albucher RC; Curtis GC
Am J Psychiatry; 2001 May; 158(5):818-9. PubMed ID: 11329414
[No Abstract] [Full Text] [Related]
33. N-Acetylcysteine augmentation in refractory obsessive–compulsive disorder.
Bhaskara S
J Psychiatry Neurosci; 2019 May; 44(3):215-216. PubMed ID: 31038300
[No Abstract] [Full Text] [Related]
34. Oral acetylcysteine for neuropsychiatric disorders.
Racz R; Sweet BV; Sohoni P
Am J Health Syst Pharm; 2015 Jun; 72(11):923-6, 928-9. PubMed ID: 25987686
[No Abstract] [Full Text] [Related]
35. N-acetylcysteine in the treatment of compulsive sexual behavior disorder: A case series.
Blum AW; Grant JE
J Psychiatr Res; 2022 Oct; 154():203-206. PubMed ID: 35952519
[TBL] [Abstract][Full Text] [Related]
36. N-Acetyl Cysteine and Curcumin in Pediatric Acute-Onset Neuropsychiatric Syndrome.
Moore K
J Child Adolesc Psychopharmacol; 2018 May; 28(4):293-294. PubMed ID: 29641241
[No Abstract] [Full Text] [Related]
37. Evidence of N-acetylcysteine efficacy for skin picking disorder: A retrospective cohort study.
Hwang AS; Campbell EH; Sartori-Valinotti JC
J Am Acad Dermatol; 2022 Jul; 87(1):148-150. PubMed ID: 34224772
[No Abstract] [Full Text] [Related]
38. Supplement may ease compulsive hair pulling.
Harv Ment Health Lett; 2009 Oct; 26(4):7. PubMed ID: 19911455
[No Abstract] [Full Text] [Related]
39. N-Acetylcysteine for Treating Compulsive Behavior: An Updated Meta-Analysis.
Shiozawa P; Generoso MB; Taiar I; Cordeiro Q
J Clin Psychopharmacol; 2016 Oct; 36(5):523-4. PubMed ID: 27529773
[No Abstract] [Full Text] [Related]
40. N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial.
Paydary K; Akamaloo A; Ahmadipour A; Pishgar F; Emamzadehfard S; Akhondzadeh S
J Clin Pharm Ther; 2016 Apr; 41(2):214-9. PubMed ID: 26931055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
